Fudan University

Running trials

• Recruiting

  Air Purifier Use and Respiratory Health in COPD Patients

  NCT07505602· Source

• Recruiting

  The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors

  NCT07159048· Source

• Not yet recruiting

  Maintenance Therapy in HER2-Positive Unresectable Locally Recurrent or Metastatic Breast Cancer: A Phase II Study

  NCT07179939· Phase 2· Source

• Recruiting

  A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma

  NCT07105592· Phase 1/2· Source

• Recruiting

  Precision Palliative Care for Patients With Advanced Esophageal Cancer

  NCT06787313· Source

• Recruiting

  Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer

  NCT06841159· Phase 2· Source

• Recruiting

  China HEalthy Aging and Dementia Study (HEAD)

  NCT07912710· Source

• Recruiting

  A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

  NCT05150691· Phase 1/2· Source

• Recruiting

  Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

  NCT05024214· Phase 1/2· Source

• Recruiting

  Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

  NCT03983226· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer3 recruiting
• Colorectal cancer2 recruiting
• Gastric and esophageal cancer2 recruiting
• Lung cancer2 recruiting
• Alzheimer disease1 recruiting
• COPD1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Kidney cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Ovarian cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  HTA of NIVATS Based on RWE

  NCT06574295· Source

• Completed

  Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

  NCT05673577· Phase 2· Source

Trial sites

• Fudan University10 trials
• School of Public Health, Fudan University2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Liver and biliary tract cancer521 works · 3 trials
• Stroke461 works · 0 trials
• Lung cancer373 works · 3 trials
• Colorectal cancer301 works · 2 trials
• Obesity255 works · 0 trials
• Alzheimer disease245 works · 1 trials
• Gastric and esophageal cancer225 works · 2 trials
• Type 2 diabetes196 works · 0 trials
• Heart failure173 works · 0 trials
• Parkinson disease138 works · 0 trials
• HIV127 works · 0 trials
• Tuberculosis127 works · 0 trials
• Prostate cancer125 works · 0 trials
• Ovarian cancer124 works · 1 trials
• Pancreatic cancer118 works · 0 trials
• Chronic kidney disease110 works · 0 trials
• Triple-negative breast cancer109 works · 0 trials
• Melanoma88 works · 0 trials
• COPD86 works · 1 trials
• Asthma84 works · 0 trials
• Fatty liver disease (MASLD/MASH)84 works · 0 trials
• Glioblastoma81 works · 0 trials
• Epilepsy78 works · 0 trials
• Coronary artery disease76 works · 0 trials
• Cervical cancer75 works · 0 trials
• Sarcoma63 works · 0 trials
• Osteoporosis62 works · 0 trials
• Bladder cancer62 works · 0 trials
• Kidney cancer53 works · 1 trials
• Atrial fibrillation51 works · 0 trials